SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (4707)7/2/1998 5:46:00 PM
From: Steve Fancy   of 6136
 
Enzo Biochem HGTV43 Shows 'High' Protection Level Vs HIV

Dow Jones Newswires

GENEVA -- -Enzo Biochem (ENZ) said laboratory
studies show its antisense-based therapeutic product,
HGTV43, provides a high level of protection against
HIV.

In a press release Thursday, Enzo said that in laboratory
studies, HGTV43 achieved a level between 92% and
more than 99% in protecting human immune cells from
infection by a broad spectrum of diverse strains of
HIV-1.

The studies were presented in Geneva at the 12th World
AIDS Conference.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News